Bicyclic piperidine derivatives as melanocortin-4 receptor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 451/02 (2006.01) A61K 31/46 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 15/00 (2006.01) A61P 15/10 (2006.01)

Patent

CA 2519939

Certain novel bicyclic N-acylated piperidine derivatives are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.

Certains nouveaux dérivés de piperidine bicycliques N-acylés sont des agonistes du ou des récepteur(s) humain(s) de la mélanocortine et, en particulier, des agonistes sélectifs du récepteur humain 4 de la mélanocortine (MC-4R). On les utilise pour traiter, contrôler ou prévenir des maladies ou des troubles sensibles à l'activation de MC-4R, tels que l'obésité, les diabètes, le dysfonctionnement sexuel, notamment le dysfonctionnement de l'érection et un dysfonctionnement sexuel de la femme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic piperidine derivatives as melanocortin-4 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic piperidine derivatives as melanocortin-4 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic piperidine derivatives as melanocortin-4 receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1681690

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.